Intraoperative fetal heart monitoring for non-obstetric surgery: A systematic review by Po', Gaia et al.
Accepted Manuscript
Title: Intraoperative fetal heart monitoring for non-obstetric
surgery: a systematic review
Authors: Gaia Po’, Carlotta Olivieri, Carl H. Rose, Gabriele
Saccone, Rebekah McCurdy, Vincenzo Berghella
PII: S0301-2115(19)30197-6
DOI: https://doi.org/10.1016/j.ejogrb.2019.04.033
Reference: EURO 10811
To appear in: EURO
Received date: 25 February 2019
Revised date: 11 March 2019
Accepted date: 18 April 2019
Please cite this article as: Po’ G, Olivieri C, Rose CH, Saccone G, McCurdy R,
Berghella V, Intraoperative fetal heart monitoring for non-obstetric surgery: a systematic
review,European Journal ofObstetrics andamp;Gynecology andReproductiveBiology
(2019), https://doi.org/10.1016/j.ejogrb.2019.04.033
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
  
 
1 
Intraoperative fetal heart monitoring for non-obstetric surgery: a systematic review 
 
Gaia PO’ MD1, Carlotta OLIVIERI MD2, Carl H. ROSE MD3, Gabriele SACCONE MD4, 
Rebekah McCURDY MD5, Vincenzo BERGHELLA MD5. 
 
1Obstetrics and Gynecology Unit, Mother-Infant and Adult Department of Medical and Surgical 
Sciences, University of Modena and Reggio Emilia, Modena, Italy  
2Sapienza University of Rome, Rome, Italy 
3Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mayo Clinic, 
Rochester, MN, USA 
4Department of Neuroscience, Reproductive Science and Dentistry, School of Medicine, 
University of Naples Federico II, Naples, Italy 
5Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Thomas 
Jefferson University Hospital, Philadelphia, Pennsylvania 
 
Corresponding author:  
Vincenzo Berghella, MD. Thomas Jefferson University, 833 Chestnut St, Philadelphia, PA 
19107, USA. Email: vincenzo.berghella@jefferson.edu 
 
ABSTRACT  
Limited data are available on fetal monitoring during non-obstetric surgery in pregnancy. We 
performed a systematic review to evaluate the incidence of emergent cesarean delivery performed 
for non-reassuring fetal heart rate patterns during non-obstetric surgery. Electronic databases were 
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searched from their inception until October 2018 without limit for language. We included studies 
evaluating at least five cases of intraoperative fetal heart rate monitoring -either with ultrasound 
or cardiotocography- during non-obstetric surgery in pregnant women at ≥22 weeks of gestation. 
The primary outcome was the incidence of intraoperative cesarean delivery performed for non-
reassuring fetal heart rate monitoring. Non-reassuring fetal heart rate monitoring was defined by 
attendant personnel, meeting NICHD criteria for category II or III patterns. Data extracted 
regarded type of study, demographic characteristics, maternal and perinatal outcomes. Statistical 
analysis was performed for continuous outcomes by calculating mean and standard deviations for 
appropriate variables. Of 120 studies identified, 4 with 41 cases of intraoperative monitoring met 
criteria for inclusion and were analyzed. Most (66%) surgeries were indicated for neurological or 
abdominal maternal issues and were performed under general anesthesia (88%) at a mean 
gestational age of 28 weeks. Minimal or absent fetal heart variability was noted in most cases and 
a 10-25 beats per minutes decrease in fetal heart rate baseline was observed in cases with general 
anesthesia. No intraoperative cesarean deliveries were needed. The incidence of non-reassuring 
fetal heart rate monitoring was 4.9% (2/41) and were limited to fetal tachycardia during maternal 
fever. Two (4.9%) cases of non-reassuring fetal heart rate monitoring were noted within the 
immediate 48 hours after surgery, necessitating cesarean delivery. A single case of intrauterine 
fetal demise occurred four days postoperatively in a woman who had neurosurgery and remained 
comatose. In conclusion, limited data exist regarding the clinical application of fetal heart rate 
monitoring at viable gestational ages during non-obstetric surgical procedures. Fetal heart rate 
monitoring during non-obstetric surgery at ≥22 weeks was not associated with need for 
intraoperative cesarean delivery, but two (4.9%) cesarean deliveries were performed for non-
reassuring fetal heart rate monitoring within 48 hours after surgery. 
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Key words: intraoperative fetal monitoring; non-obstetric surgery; non-reassuring fetal 
monitoring during non-obstetric surgery; emergency cesarean delivery during non-obstetric 
surgery. 
 
INTRODUCTION 
Non-obstetric surgery is required in approximately 1-2% of pregnancies.1 In the United States 
alone, this equates to about 40,000-80,000 pregnant women undergoing antepartum surgical 
procedures yearly.  The evaluation of fetal well-being during non-obstetric surgery is often an area 
of divergent clinical practice due to the limited evidence. While the need for pre- and postoperative 
assessment of fetal heart rate (FHR) has been proposed,2 there is no consensus regarding 
intraoperative fetal heart rate monitoring (iFHRM). The American College of Obstetricians and 
Gynecologists (ACOG) has stated that the decision to use iFHRM should be individualized, based 
on factors such as gestational age, type of surgery, and available resources.3  
Many studies and case reports have described management and outcomes of non-obstetric surgery 
in pregnancy,4-11 but there is an absence of randomized controlled trials, and to our knowledge, no 
systematic review has evaluated the use of iFHRM on obstetric and neonatal outcomes in pregnant 
women who underwent non-obstetric surgery at a viable gestational age (22 weeks).  
Objective 
The aim of this systematic review was to evaluate the incidence of intraoperative cesarean delivery 
for non-reassuring iFHRM (NRiFHRM) during non-obstetric surgery ≥22 weeks.  
 
MATERIALS AND METHODS 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
4 
Search strategy 
This review was performed according to a protocol designed a priori and recommended for 
systematic review.12 Electronic databases (MEDLINE, clinicaltrials.gov and Cochrane Library, 
PROSPERO, Scopus, Science direct) were searched from their inception until October 2018 
without restrictions on publication language. Employed search terms included: “fetal heart rate 
monitoring”, “intraoperative fetal monitoring”, “non-obstetric surgery” and “emergency cesarean 
delivery during non-obstetric surgery”. In addition, the bibliographies of all identified articles were 
reviewed to identify studies not captured by electronic searches. Eligibility of the studies was 
assessed independently by two authors (GP, CO); differences were resolved through discussion 
with a third author (VB).  
Study selection 
We included randomized controlled trials, cohort studies, case-control studies, and case series 
evaluating use of iFHRM during non-obstetric surgery in pregnant women. Case reports and 
studies describing fewer than five cases, all previable cases (<22 weeks of gestation), studies 
without defined gestational ages, and studies without details about intraoperative fetal monitoring 
were excluded.  
Data extraction 
Data extraction was completed by 2 independent investigators (GP, CO); disparities were resolved 
by consensus with a third reviewer (VB). Before data extraction, the review was registered with 
the PROSPERO International Prospective Register of Systematic Reviews (registration no.: 
CRD42018114205). The review was reported according to the Preferred Reporting Item for 
Systematic Reviews and Meta-analyses statement.13 
Assessment of risk of bias 
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Two reviewers (GP, GS) independently assessed the risk of bias of the included studies via the 
Methodological Index for Non-Randomized Studies.14 Seven domains that are related to risk 
of bias were assessed in each study: (1) aim (i.e., clearly stated aim), (2) rate (i.e., inclusion of 
consecutive patients and response rate), (3) data (i.e., prospective collection of data), (4) bias (i.e., 
unbiased assessment of study end points), (5) time (i.e., follow-up time appropriate), (6) loss (i.e., 
loss to follow-up), (7) size (i.e., calculation of the study size). Review authors’ judgments were 
categorized as “low risk,” “high risk” or “unclear risk of bias.” Discrepancies were resolved by 
discussion with a third reviewer (VB). 
Outcomes 
The primary outcome was the incidence of cesarean delivery performed for non-reassuring iFHRM 
(NRiFHRM). Secondary outcomes were incidence of NRiFHRM during surgery in absence of 
maternal vital sign changes, rate of cesarean delivery performed postoperatively (within 48 hours 
after surgery), rate of preterm birth, and neonatal outcomes, including birthweight, APGAR score 
<7 at 5 minutes, intrauterine fetal demise, neonatal death, respiratory distress syndrome, cerebral 
palsy and admission to the neonatal intensive care unit (NICU). 
In principle, NRiFHRM was defined as NICHD category II or III characteristics15 when iFHRM 
was performed using CTG and as refractory bradycardia (<110/minute) or tachycardia 
(>160/minute) when iFHRM was performed exclusively via ultrasound. Minimal or absent fetal 
heart rate variability was not considered as criteria for NRiFHRM since induction and maintenance 
of general anesthesia is commonly associated with these phenomena.16 Maternal vital sign changes 
were defined as sustained maternal tachycardia (>100/minute), blood pressure <90/40 mmHg, 
hyperthermia (> 38˚C) and hypoxemia (defined as SaO2 <95% oxygen saturation).  
Statistical analysis 
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Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) v. 19.0 
(IBM Inc., Armonk, NY, USA). Data are shown as means ± standard deviation (SD), or as medians 
(range), or as number (percentage). Univariate comparisons of dichotomous data were performed 
with the use of the chi-square or Fisher exact test. Comparisons between groups were performed 
with the use of the Mann-Whitney U test, to test group medians with range; and with the use of 
the T-test or the One-way ANOVA to test group means with SD. 
 
RESULTS  
Study selection and study characteristics 
We identified 120 publications with primary subject of non-obstetric surgery in pregnancy (Figure 
1). Eighty-nine (74.2%) reported about iFHRM during non-obstetric surgery, and 50 (56.2%) 
reported specific information on iFHRM.  Four (3.3% of the total)17-20 were case series including 
5 cases with details of iFHRM during non-obstetric surgery performed at 22weeks. The quality 
of the studies included in our review was assessed by the Methodological Index for Non-
Randomized Studies’ tool14 for assessment of the risk of bias (Figure 2). All studies had low risk 
of bias in “aim” and “time”. Three of them were retrospective case series;17, 19, 20 1 study had 
prospective design.18 One author provided subsequent additional unpublished data (CR).20 
The four included studies reported a total of 155 non-obstetric surgical procedures in pregnancy, 
of which 148 (95.5%) were performed at 22 weeks gestation (Table 1). Of these, 41 (27.7%) had 
iFHRM recorded. The mean gestational age at surgery was 28.6 ± 4.2 weeks.  
Characteristics of the surgeries are shown in Table 2. The most common indications for surgery 
were neurological (34.1%) and abdominal (31.7%) pathology, and most women (87.8%) 
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underwent general anesthesia, for elective (58.5%) procedures, lasting approximately one hour and 
40 minutes.  
Maternal monitoring during surgery is shown in Table 3. Most (73.2%) women were placed in a 
left lateral position. Details of any changes in maternal heart rate, blood pressure and pulse 
oximetry were reported exhaustively only for 7 women, with 2 reported to have fever during 
episodes of concurrent fetal tachycardia. 
Synthesis of results 
Primary outcome 
Details of iFHRM during surgery are reported in Table 4. iFHRM was done by either CTG (21, 
51.2%) or ultrasound (15, 36.6%); in 5 cases the exact type of iFHRM was not recorded.  Specific 
information about FHR patterns was available only for 15 cases (36.6%): 14 with CTG and 1 with 
ultrasound. Overall, 2 (4.9%) had NRiFHRM: these were 2 cases of fetal tachycardia, one detected 
with CTG (>180 beats per minute for 25 minutes) and the other with ultrasound.  
The case of tachycardia registered with CTG occurred in a febrile patient at 23 4/7 weeks during 
an exploratory laparotomy for removal of a right adnexal mass under epidural anesthesia; fetal 
tachycardia resolved immediately after the surgical procedure was completed. The case of fetal 
tachycardia detected by ultrasound occurred in a patient at 24 3/7 weeks during an emergent 
laparotomy for acute appendicitis under general anesthesia. Maternal blood pressure, heart rate, 
and pulse oximetry remained stable during the surgery, but hyperthermia (38.1°C) was reported. 
The fetal heart rate baseline returned to 125/minute at the end of the surgical procedure; after the 
patient was extubated and transferred to the transport bed, refractory fetal bradycardia was noted 
and emergent cesarean delivery performed.  
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Two of the included studies with details of iFHRM reported minimal or absent FHR variability in 
13/15 patients (86.7%), most pronounced with general anesthesia; four of which (30.8%) occurred 
in the second trimester. Variability of the FHR returned to moderate with emergence from the 
anesthesia in 9 cases and persisted for 95-180 minutes in 4 cases. Among 11 cases under general 
anesthesia, 9 (81.8%) reported a decrease in FHR baseline by 10-25/minute. There were no other 
cases of NRiFHRM, and all other reported cases had stable maternal vital parameters 
intraoperative. No cases necessitated cesarean for NRiFHRM (Table 5).  
Secondary outcome: 
Tocolysis was employed in 7 (25.9%) cases (Table 5); 6 cases occurred in the third trimester, 5 
were abdominal procedures (3 appendectomies, 1 cholecystectomy, 1 removal of an adnexal mass) 
and 2 were mastectomies. All of these women delivered at term.  
Obstetrical and perinatal outcomes are shown in Table 6. Data on gestational age at delivery were 
complete in only two studies, reporting a mean gestational age at delivery of 34.2 ± 6 and 36 ± 8.1 
weeks, respectively. Preterm birth occurred in 9/36 (25%) cases, of which 5/9 (55.6%) occurred 
within 48 hours after abdominal surgery. Three of these were cesarean deliveries performed (1) 
for fetal bradycardia immediately after surgery at 24 3/7 weeks (case described above), (2) for 
intra-abdominal hemorrhage with maternal hypotension on postoperative day 1 after hepatic 
resection at 26 6/7 weeks, and (3) for non-reassuring fetal non-stress test on post-operative day 2 
after a skin graft for burn at 24 2/7 weeks. The other two were spontaneous preterm births occurring 
after abdominal surgery within 48 hours post-operative (one operative vaginal delivery secondary 
to a placental abruption at 32 2/7 weeks and one spontaneous vaginal delivery at 28 3/7 weeks).  
Preterm births occurred greater than 48 hours postoperative in 4 (44.4%) patients; 2 occurred in 
patients who underwent neurosurgery: 1 delivery at 31 weeks (7 days postoperative) occurred 
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following surgery for a closed head injury subsequent to a motor vehicle accident, with low 
neonatal Apgar scores recorded at birth (no further information available), and the other case was 
an intrauterine fetal demise with spontaneous onset of labor at 26 4/7 weeks after craniotomy for 
a spontaneous intracerebral hemorrhage 4 days before (no further information available). Both 
patients presented and remained in comatose status at the time of surgery. The remaining preterm 
births occurred at 32 3/7 and 35 2/7 weeks, 10 days after a cystoscopy with stent placement and 5 
weeks after an appendectomy, respectively.Among overall spontaneous preterm births, 3 cases of 
preterm delivery followed abdominal procedures, 2 occurred after neurologic procedures and 1 
after a urologic procedure.  
Two cases (8.3 %) of low APGAR scores at birth and 1 (3.1%) intrauterine fetal demise occurred 
in patients who underwent neurosurgery (as described above). No other adverse neonatal outcomes 
were reported. 
 
COMMENT 
Main findings 
This systematic review of women undergoing antepartum non-obstetric surgery at ≥22 weeks 
gestation in which intraoperative fetal monitoring was performed identified three findings:  
 Cesarean delivery was not performed in any case for NRiFHRM. 
 In cases where NRiFHRM was identified, this was explicable secondary to a maternal 
etiology. No cases of NRiFHRM occurred with stable maternal vital signs. 
 Delivery for NRiFHRM was required within 48 hours postoperative in about 5% of 
women. 
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As no cases of intraoperative NRiFHRM were described with stable maternal vital parameters, the 
risk of a pathologic fetal heart pattern appears to be confined to intraoperatively febrile or 
hemodynamically unstable patients. The preterm birth rate in this cohort was high (25%); the 
majority of preterm deliveries in the first 48 hours postoperative were consequent to cesarean 
delivery. Adverse neonatal outcomes, including the only stillbirth, were limited to patients who 
underwent neurosurgical procedures while comatose. 
Comparison with prior literature 
To our knowledge, this may be the first systematic review to review iFHRM at ≥22 weeks during 
non-obstetrics surgery. Other reviews21, 22 evaluated obstetric and perinatal outcomes after non-
obstetric surgery without iFHRM, and therefore are unable to address the incidence of 
intraoperative NRiFHRM, FHR patterns and the rate of cesarean delivery for NRiFHRM during 
surgery. A previous review23 evaluated the practice of iFHRM, including 9 pregnant women at 
various gestational ages (including non-viable pregnancies) who underwent non-obstetric surgical 
procedures; as no instances of fetal demise were encountered, the authors concluded there was no 
evidence-based benefit to the practice.23  
FHR patterns can be affected directly by anesthetic medication crossing the placenta or indirectly 
by changing in maternal hemodynamics as a result of anesthesia and surgery.24 In our review, the 
only intraoperative NRiFHRM registered was tachycardia, and every case occurred in association 
with maternal fever, a known cause. A previous study25 reported that elevated FHR baseline can 
also represent a side-effect of maternal drug administration (e.g. atropine). Both cases of 
NRiFHRM occurred under general anesthesia. Unfortunately, the sample size of our study is too 
limited for further evaluation regarding effects of different types of anesthesia on the incidence of 
NRiFHRM, but another author21 previously demonstrated no association between the type of 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 
11 
anesthesia and adverse fetal and neonatal outcomes in pregnancy of any gestational age following 
non-obstetric surgery. 
Temporary decreases in the FHR baseline and variability is a well-described effect of anesthetic 
drugs,16, 25-27, 30 confirmed also in our review. FHR variability always returned to moderate with 
discontinuation of inhalation anesthesia. Our study supports the fact that minimal/absent 
variability during general anesthesia without decelerations is not a sign of fetal compromise.  
The preterm birth rate in the current study was higher than in the general population of the United 
States (9.9%)28 and 50% of cases of spontaneous preterm labor happened after abdominal surgery. 
Previous studies have found divergent results regarding the risk of preterm birth following non-
obstetric surgery during pregnancy.21, 22, 29 For each study, it was impossible to definitively 
conclude if preterm labor was caused by the operative procedure itself or provoked by the disease 
process necessitating the surgery. Indeed surgery, manipulation of the uterus, as well as 
inflammatory diseases (e.g. appendicitis) could potentially activate similar pathophysiological 
pathways of cortisol and cytokine release leading to preterm birth.30 
Another review, including 12,542 pregnant women who underwent surgery during pregnancy from 
1966-2001,29 showed an increased risk of fetal loss (2.5%). In our study, although the stillbirth 
rate (3.1%) was similar, this occurred in a comatose patient thus we cannot exclude that the fetal 
demise could be related to the clinical scenario instead of the surgery. In a retrospective study 
including 5,405 women, Mazze et. al21 demonstrated that the rates of low birthweight infants and 
early neonatal death were significantly increased in women who had had surgery. Unfortunately, 
we were not able to evaluate birthweight due to limitations in source data, however no immediate 
neonatal deaths were noted.  
Strengths and limitations 
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Our systematic review has several strengths. It is the first evaluating cesarean delivery rate for 
NRFHRM in pregnant women undergoing non-obstetric surgery at ≥22 weeks of gestation. We 
included only case series with 5 patients or more in order to reduce publication bias.  
Limitations of our study are inherent to the limitations of the included studies. The bias assessment, 
shows that most of the included studies had moderate risk of bias. Our systematic review retrieved 
no randomized trials. All of the included studies were case series without controls, with limited 
number of patients and different objectives; indeed only two of them sought to specifically 
evaluate FHR changes during maternal surgery. Most of the cases included in this review 
underwent high-acuity surgical procedures and this could have influenced the type of post-
operative fetal monitoring and also obstetric outcomes. Unfortunately, no information regarding 
the types of post-operative monitoring were available. Furthermore, two of the studies were not 
recent17,18 and may not reflect contemporary obstetric practice. Some outcomes (e.g. mean 
gestational age at delivery, birthweight, maternal vital sign changes) were not reported. Although 
all authors of the included studies were contacted, only 1 provided the missing information. We 
were not able to find any eligible case series of pregnant women undergoing cardiac surgery with 
iFHRM. Finally, the small number of patients did not allow us to perform sub-analysis for the 
different types of surgery or techniques (e.g. laparoscopic or open surgery). 
Implications 
During non-obstetric surgery, in limited data, NRiFHRM or stillbirth appear to occur only in 
presence of maternal vital sign changes. Therefore, iFHRM seems most beneficial in situations 
where unstable maternal vital signs are anticipated, and it is practically feasible to temporarily 
suspend the primary procedure to permit emergent cesarean delivery to be performed.  
Conclusion 
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Non-reassuring fetal heart patterns during non-obstetric surgery at ≥22 weeks were limited to fetal 
tachycardia due to maternal fever and did not require intraoperative cesarean delivery in any case. 
As in 5% of cases cesarean deliveries were necessary for non-reassuring fetal heart rate monitoring 
within 48 hours after surgery, postoperative fetal monitoring should be considered, especially in 
cases where unstable vital signs are anticipated. Recognizing that at present there is minimal 
existent data regarding the practice of intraoperative fetal monitoring during antepartum non-
obstetric surgery, the current study represents the most comprehensive review to date. 
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TABLES 
 
Table 1. Study and demographic characteristics 
 
Author Type of study Primary outcome Total 
operative  
procedures 
(N) 
Operative 
procedures  
22 weeks (N) 
Procedure 
with FHRM 
 22 weeks 
(N)  
Maternal 
age, mean 
± SD 
(years) 
GA at 
surgery, 
mean ± 
SD 
(weeks) 
Liu 1985 Retrospective 
case series 
FHR changes and 
uterine activity 
during maternal 
surgery 
5 5 5 28.2 ± 8.6 31.8 ± 
2.9 
Kendrick 
1994 
Prospective 
case series 
FHR changes and 
uterine activity 
during maternal 
surgery 
10 8 8  24.8 (range 
19-36) 
27.6 ± 
4.2 
Cohen-
Gadol 2009 
Retrospective 
case series 
Identifying optimal 
management 
strategies for 
intracranial 
pathological 
entities in pregnant 
women 
19 14 14 26.9 ±  3.8  27.3 ±  
4.4  
Baldwin  
2015 
Retrospective 
case series 
Incidence of 
preterm delivery 
after non-obstetric 
surgical procedures 
performed at 
viable fetal 
gestational 
ages. 
121 121 14  27.2 ±4.6 29.4 ± 
3.9 
Total 1 (25%) 
prospective 
case series 
3 (75%) 
retrospective 
case series 
- 155 148/155 
(95.5%) 
41/148  
(27.7%) 
27.2 ±4.9 28.6 ± 
4.2 
GA, gestational age; FHR, fetal heart rate  
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Table 2. Surgery characteristics 
 
 
LPS, laparoscopic; VATS, video-assisted thoracoscopic surgery  
* Data available for 13 women 
Author Type of surgery, N (%) Characteristics of surgery 
(emergent/urgent/ 
elective), N (%) 
Duration of 
surgery in 
minutes (mean) 
Type of 
anesthesia, N 
(%) 
Liu 1985 3 Abdominal  
(2 appendectomy, 1 
lysis of adhesions) 
1 Thoracic (mastectomy) 
1 Other  
(debridement and skin 
grafting) 
 
1 Elective 
3 Urgent 
1 Emergency 
126.6± 77.3 5 General 
Kendrick 
1994 
  
  
  
  
  
  
3 Abdominal   
(1cholecystectomy, 1 
appendectomy, 1 
removal of an adnexal 
mass) 
1 Urologic  
(urolithiasis) 
2 Thoracic  
(mastectomy) 
1 Orthopedic 
1 Other  
(cervical conization) 
6 Elective 
2 Urgent  
 
  
  
  
  
  
82.8 ±54.6 
  
  
  
  
  
6 (75) General  
2 (25) 
Neuraxial 
  
  
  
  
  
Cohen-
Gadol  
2009 
14 Neurosurgery  
(7 vascular lesions, 4 
tumors, 3  trauma and 
hemorrhage) 
12 Elective 
2 Emergent 
Not reported 14 (100) 
General 
anesthesia 
Baldwin 
2015 
  
  
  
  
7 Abdominal  
(3 appendectomy, 2 
intestinal resection, 1 
LPS cholecystectomy, 
1 hepatic surgery) 
3 Urologic  
(3 cystoscopy and 
stent placement) 
2 Thoracic  
(mastectomy, VATS) 
1 Orthopedic 
1 Other  
(parathyroid ) 
5 Elective 
5 Urgent  
4 Emergent  
 
  
Not reported 
  
  
  
  
11 (79) 
General 
3 (21) 
Neuraxial  
 
 
Total 14 (34.1) Neurosurgery 
13 (31.7) Abdominal  
4 (9.8) Urologic 
5 (12.2) Thoracic 
2 (4.9) Orthopedic 
3 (7.3) Other 
 
24 (58.5) Elective 
10 (24.4) Urgent 
7 (17.1) Emergent 
99.6 ± 65* 36 (87.8) 
General  
5 (12.2) 
Neuraxial AC
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Table 3. Maternal monitoring during surgery 
 
Author 
Maternal 
position, N 
(%) 
Changes in 
maternal heart 
rate 
Changes in 
maternal blood 
pressure 
Changes in 
maternal 
temperature 
Changes in 
maternal pulse 
oximetry 
Liu 1985 
5 Left lateral 
tilt 
None None None None 
Kendrick 
1994 
8 Left lateral 
tilt 
Not reported Not reported 
One case of  
fever during fetal 
tachycardia 
Not reported 
Cohen-
Gadol 2009 
14 Lateral 
decubitus 
Not reported Not reported Not reported Not reported 
Baldwin 
2015 
3 Left lateral 
5 Dorso-
lithotomy  
6 Not recorded 
Not reported Not reported 
One case of  
fever during fetal 
tachycardia 
Not reported 
Total 
30 (73.2) 
Lateral  
5 (12.2) Dorso-
lithotomy 
6 (14.6) Not 
recorded 
Not reported Not reported Not reported Not reported 
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Table 4. Details of fetal heart rate monitoring during surgery 
 
 
FHR: Fetal heart rate; NRiFHRM: Non-reassuring intraoperative fetal heart rate monitoring; US, ultrasound. 
 
  
Author Type of monitoring FHR patterns 
recorded, N 
(%), details 
Number of 
NRiFHRM 
Details of 
NRiFHRM 
Type of 
surgery during 
NRiFHRM 
Type of 
anesthesia 
during 
NRiFHRM 
NRiFHRM 
in absence of 
maternal VS 
changes 
Liu 1985 5 CTG  (uterine 
activity not evaluated 
in 4 procedures) 
5/5 (100) 
reduced/absent 
variability with 
the 
administration 
of general 
anesthesia, in 3 
cases decreased 
FHR baseline 
0  
  
Not 
applicable 
Not applicable Not 
applicable 
Not 
applicable 
Kendrick 
1994 
  
8 CTG 
(uterine activity 
evaluated with 
palpation in 3 
procedures) 
8/8 (100) 
Loss of 
variability, 
decrease of 10-
25 bpm with 
general 
anesthesia,  
decrease of 5 
bpm with spinal 
anesthesia 
1  
  
Tachycardia  
  
Exploratory 
laparotomy 
with excision 
of an adnexal 
mass 
  
1 Neuraxial 
anesthesia 
No 
(tachycardia 
was believed 
a fetal 
response to 
maternal 
fever) 
  
  
Cohen-
Gadol 
2009 
  
14 US continuous or 
intermittent  
 
Not reported 0 Not reported Not reported Not 
reported 
Not reported 
Baldwin 
2015 
8 CTG  
(7 
Continuous 
/1 
Intermittent) 
1 US intermittent 
(appendectomy) 
5 Not recorded 
2/14 (14.3),  
One category I 
CTG, one 
tachycardia at 
the US 
1  Tachycardia  Exploratory 
laparotomy 
with 
appendectomy 
1 General 
anesthesia 
No 
(tachycardia 
occurred 
during 
maternal 
fever) 
Total 21 (51.2) CTG (19 
continuous/2 
intermittent) 
15 (36.6) US 
5 (12.2) Not recorded 
15/41 (36.6) 2/41 (4.9%) Tachycardia Abdominal 
procedures 
1/2 (50) 
Neuraxial 
anesthesia 
1/2 (50) 
General 
anesthesia 
No 
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Table 5. Intraoperative and post-operative intervention for maternal-fetal complications 
 
Author Intraoperative CD 
performed for 
NRiFHRM, N (%) 
Emergent CD 
performed for 
NRFHRM within 
48 hours post-
operative, N (%) 
Type of surgery 
when emergent CD 
for NRFHRM was 
performed  
Need for tocolysis, 
N (%) 
Type of surgery 
when tocolysis was 
used 
Liu 1985 0 (0) 1/5 (20) Skin graft 
subsequent a burn 
3/5 (60) 2 abdominal and 1 
mastectomy 
Kendrick 
1994 
0 (0)  0/8 - 4/8 (50)  3 abdominal and 1 
mastectomy  
Cohen-Gadol 
2009 
0 (0)  0/14 - Not reported  Not reported 
Baldwin 2015 0 (0) 1/14 (7.1) Appendectomy 0/14  None 
Total  0 (0) 2/41 (4.9) 1 skin graft, 1 
appendectomy 
7/27 (25.9)* 5 abdominal and 2 
mastectomy  
 
CD, Cesarean delivery; NRiFHRM, Non-reassuring intraoperative fetal heart rate monitoring; NRFHRM, Non-
reassuring fetal heart rate monitoring. 
* Data available for 27 patients 
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Table 6. Obstetrics and perinatal outcomes 
 
 
GA, gestational age; PTB, preterm birth; BW, birth weight; CD, cesarean delivery; NRFHRM, non-reassuring fetal 
heart rate monitoring; FAVD, forceps-assisted vaginal delivery; SVD, spontaneous vaginal delivery. 
*Including neonatal death, respiratory distress syndrome, cerebral palsy and admission to neonatal intensive care 
unit 
** One ongoing pregnancy, one case with unknown pregnancy outcome. 
***Three patients lost at follow-up 
†Data available for 7 women 
 
Author GA at 
delivery, 
mean 
±SD 
PTB, N (%) PTB 
within 48 
hours 
post-
operative, 
N (%) 
Details of PTB within 48 
hours post-operative 
BW (gr) APGAR < 
7 at 5 
minutes, 
N (%) 
Stillbirths, 
N (%) 
Other 
adverse 
perinatal 
outcomes, 
N (%)* 
Liu 1985 36 ± 8.1 1/5 (20) 1/1 (100)  1 emergent CD for 
NRFHRM on post-
operative day 2 after a 
skin graft for a burn at 24 
2/7 weeks. 
3167±1006 0/5 (0) 0/5 (0) 0/5 (0) 
Kendrick 
1994 
All at 
Term 
(not 
reported 
GA in 
weeks) 
0/8 (0)  0 (0) None 3374 
(2764-
4791) 
Not 
reported 
0/8 (0) 0/8 (0) 
Cohen-
Gadol 
2009 
Not 
reported 
2/12**(16.7) 
 
0 (0) None Not 
reported 
2/12 
(16.7)**  
1/12 
(8.3)**  
0/12** 
Baldwin 
2015 
34.2 ± 6 6/11***(54.5) 4/6 (66.7) 1 emergent CD for 
refractory fetal 
bradycardia immediately 
after appendectomy at 24 
3/7 weeks; 1 emergent 
CD for intra-abdominal 
hemorrhage with maternal 
hypotension on 
postoperative day 1, after 
hepatic resection at 26 6/7 
weeks; 1 FAVD 
secondary to a placental 
abruption at 32 2/7 weeks 
on post-operative day 2, 
after an intestinal 
resection; 1 SVD at 28 
3/7 weeks on post-
operative day 2, after a 
subtotal colectomy and 
ileostomy. 
Not 
reported 
0/7 (0)† 0/7 (0)† 0/7 (0)† 
Total  - 9/36 (25) 5/9 (55.6) 3 emergent CD; 2 
spontaneous preterm 
labors 
- 2/24 (8.3) 1/32 (3.1) 0/32 (0) CC
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FIGURES 
Figure 1. Flow diagram of studies identified in the systematic review. Preferred Reporting Item for Systematic 
Reviews and Meta-analyses (PRISMA) template. Definition of terms: FHRM: fetal heart rate monitoring; iFHRM: 
intraoperative fetal heart rate monitoring.  
 
Figure 2. Assessment of risk of bias. Definition of terms: Aim, clearly stated aim; Rate, inclusion of consecutive 
patients and response rate; Data, prospective collection of data; Bias, unbiased assessment of study endpoints; Time, 
follow-up time appropriate; Loss, loss to follow-up; Size, calculation of the study size. AC
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